Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes

Abstract In patients with diabetes, functional changes in microcirculation and subclinical vascular pathology precede clinical manifestation of microangiopathic complications. The objective of this study was to evaluate the association between established vascular risk factors and density, maturity, and reactivity of dermal blood vessels in adults with type 1 diabetes (DM1). We included 148 DM1 patients (87 men) with a median (IQR) age of 40.5 (30.5–49) years and a median diabetes duration of 21 (17–29.5) years. The control group consisted of 13 healthy volunteers (6 men) with a median (IQR) age of 36 (31–43). Accumulation of advanced glycation end products (AGEs) was assessed using the AGE-Reader device. In the immunohistochemical (IHC) analyses, anti-CD133, anti-CD34, anti-CD31, and anti-vWF autoantibodies were used. Microvessel density (MVD) in the skin was calculated using the “hot spots technique”. Microvascular function was examined by single-point laser-Doppler flowmetry (LDF). Median MVD, calculated for both papillary and reticular dermis, for CD31 antigen expression was 38 (19–56) per 1 mm 2 . The median CD34+ blood vessel density was 121 (100–155) per 1 mm 2 , CD133+ was 79 (63–92) per 1 mm 2 , and vWF+ was 50 (40–69) per 1 mm 2 . The average CD34/CD31 index was 2.78, the vWF/CD31 ratio was 1.32 and the CD133/CD31 ratio was 1.75. The CD34/CD31 index was positively associated with serum triglyceride concentration (Beta: 0.26, p  = 0.012) and negatively associated with serum HDL cholesterol concentration (Beta: −0.22, p  = 0.027), both independently from age, sex, diabetes duration, BMI, HbA1c value, presence of hypertension, and eGFR. We found a negative correlation between MVD assessed by CD31 and skin AF ( r  = −0.21, p  = 0.016). In LDF, the area under the blood flow/time curve (AUC) correlated positively with CD31+ MVD ( r  = 0.21, p  = 0.011) and negatively with CD34+ MVD ( r  = −0.20, p  = 0.017). The MVD did not differ between participants with diabetes and healthy controls, and it did not differ according to the presence of retinopathy among the participants with diabetes. Atherogenic dyslipidemia is associated with increased formation of new blood vessels, characterized by high expression of CD34 and low reactivity in LDF. Conversely, chronic hyperglycemia and excessive formation of AGEs may result in decreased vascularity.